Wealth Enhancement Advisory Services, LLC Veracyte, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,199 shares of VCYT stock, worth $566,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,199
Previous 8,177
122.56%
Holding current value
$566,716
Previous $323,000
66.87%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
76.8MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$256 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$243 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$206 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$131 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$95.9 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...